PHARMACYTE BIOTECH, INC. (PMCB) Operating cash flow 2017–2026
PHARMACYTE BIOTECH, INC. (PMCB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.2MFY2026 · since FY2017: -$3.3M → -$5.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$5.2M | -73.0% |
| FY2025 | -$3.0M | -38.4% |
| FY2024 | -$2.2M | +43.3% |
| FY2023 | -$3.8M | +7.9% |
| FY2022 | -$4.1M | -23.6% |
| FY2021 | -$3.3M | -42.4% |
| FY2020 | -$2.3M | +18.7% |
| FY2019 | -$2.9M | +43.3% |
| FY2018 | -$5.1M | -52.1% |
| FY2017 | -$3.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice